Comment on “Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal” Ross A. Abrams Commentary 14 September 2012 Pages: 2481 - 2485
Comment on “Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal” Paula GhanehCatrin Tudur-SmithJohn P. Neoptolemos Commentary 14 September 2012 Pages: 2487 - 2490
Adjuvant Therapy in Pancreatic Cancer: A Critical Appraisal — The Authors’ Reply Helmut OettlePeter Neuhaus Commentary 14 September 2012 Pages: 2491 - 2493
Potential Pharmacological Interventions in Polycystic Kidney Disease Amirali MasoumiBerenice Reed-GitomerRobert W. Schrier Leading Article 14 September 2012 Pages: 2495 - 2510
Crohn’s Disease Julián PanésFernando GomollónVilar Nos Review Article 14 September 2012 Pages: 2511 - 2537
Pharmacotherapy for Oesophagogastric Cancer Christopher JacksonNaureen StarlingDavid Cunningham Review Article 14 September 2012 Pages: 2539 - 2556
Defining the Role of Insulin Detemir in Basal Insulin Therapy Javier Morales Review Article 14 September 2012 Pages: 2557 - 2584
Cetuximab Stephanie K. A. BlickLesley J. Scott Adis Drug Evaluation 14 September 2012 Pages: 2585 - 2607
Delayed-Release Multi Matrix System (MMX™) Mesalazine Paul L. McCormackDean M. RobinsonCaroline M. Perry Adis Drug Profile 14 September 2012 Pages: 2635 - 2642
Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis Åke Nilsson Adis Drug Profiles 14 September 2012 Pages: 2643 - 2643
Delayed-Release Multi Matrix System (MMX™) Mesalazine in Ulcerative Colitis Cosimo Prantera Adis Drug Profiles 14 September 2012 Pages: 2643 - 2644
Imatinib Sarah A. CrossKatherine A. Lyseng-Williamson Adis Drug Profile 14 September 2012 Pages: 2645 - 2654
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia Joseph Brandwein Adis Drug Profiles 14 September 2012 Pages: 2655 - 2655
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia Ronan Swords Adis Drug Profiles 14 September 2012 Pages: 2655 - 2655
Imatinib in Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia Barbara Wassmann Adis Drug Profiles 14 September 2012 Pages: 2655 - 2656